Home > Insider Trading > Merck & Co. Inc. > Profile

Merck & Co. Inc. (MRK)

Sector: Pharmaceutical Preparations

Related Insiders

N Cristal Downing, Chief Comm. & Public Afrs Ofcr, 2021-08-25
A Michael Klobuchar, Evp - Chief Strategy Officer, 2021-07-15
C Peter Wendell, Director, 2021-07-02

N Cristal Downing, Chief Comm. & Public Afrs Ofcr, 2021-08-25
A Michael Klobuchar, Evp - Chief Strategy Officer, 2021-07-15
C Peter Wendell, Director, 2021-07-02
H Thomas Glocer, Director, 2021-07-02
E Christine Seidman, Director, 2021-07-02
Ellen Mary Coe, Director, 2021-07-02
F Patricia Russo, Director, 2021-06-02
J Kathy Warden, Director, 2021-06-02
G Inge Thulin, Director, 2021-06-02
Paul Rothman, Director, 2021-06-02
Stephen Mayo, Director, 2021-06-02
J Risa Lavizzo-Mourey, Director, 2021-06-02
J. Pamela Craig, Director, 2021-06-02
A Leslie Brun, Director, 2021-06-02
Frank Clyburn, Evp & Pres ? Human Health, 2021-05-11
Y Dean Li, Executive Vp & President, Mrl, 2021-05-06
Caroline Litchfield, Evp & Cfo, 2021-05-06
Steven Mizell, Evp, Chief Hr Officer, 2021-05-06
Michael David Williams, Evp,chief Info&digital Officer, 2021-05-06
Jennifer Zachary, Evp, General Counsel, 2021-05-06
Lisa Lecointe-Cephas, Svp Chief Ethics & Com Officer, 2021-05-06
A Rita Karachun, Sr. Vp Fince-Global Controller, 2021-05-06
L. Julie Gerberding, Evp Strat Comm, Gi Pub Policy, 2021-05-06
C Kenneth Frazier, Chairman & Ceo, 2021-05-06
R. Richard Deluca, Evp&pres, Merck Animal Heallth, 2021-05-06
M Robert Davis, President, 2021-05-06
Sanat Chattopadhyay, Exe V-P & Pres. Mmd, 2021-05-06
Michael Nally, Evp, Chief Marketing Officer, 2021-03-02
Michael Fleming, Svp Chief Ethics & Com Officer, 2021-03-02
R Thomas Cech, Director, 2020-06-02
P Wendell Weeks, Director, 2020-05-07
M Roger Perlmutter, Exe V-P & Pres, Mrl, 2020-05-05
B Rochelle Lazarus, Director, 2020-04-02
H James Scholefield, Evp,chief Info&digital Officer, 2019-11-01
H John Noseworthy, Director, 2019-04-02
H Adam Schechter, Evp & Pres-Global Human Health, 2018-11-02
Ashley Watson, Svp Chief Ethics & Com Officer, 2018-11-01
B. Craig Thompson, Director, 2018-05-29
M Mirian Weir Graddick, Exe V-P, Hr, 2018-05-08
J Michael Holston, Evp, General Counsel, 2018-03-02
D Adele Ambrose, Sr.v-P & Chief Comuns Officer, 2017-09-06
E Carlos Represas, Director, 2017-05-30
Robert C Kidder, Director, 2017-05-12
Clark Golestani, Evp & Chief Info Officer, 2016-08-10
Michael Rosenblatt, Exec V-P & Chief Med Officer, 2016-05-12
Jr B William Harrison, Director, 2016-04-13
A Willie Deese, Exe V-P & Pres. Mmd, 2016-02-24
N Bruce Kuhlik, Exe V-P & Gen Counsel, 2015-05-05
P Bridgette Heller, Exe.vp & Pres.con.hlth.care, 2014-05-13
John Canan, Sr.v-P Finc-Global Controller, 2014-02-26
N Peter Kellogg, Exe V-P & Cfo, 2014-02-26
V Cuong Do, Evp & Chief Strategy Officer, 2013-05-08
S Peter Kim, Exe V-P & Pres, Mrl, 2013-02-27
Iii S Richard Bowles, Exe Vp&chief Ethics & Comploff, 2012-05-10
Chris J Scalet, Exe V-P Global Srvs & Cio, 2012-05-04
M Anne Tatlock, Director, 2012-04-03
N Willam Kelley, Director, 2012-04-03
F Steven Goldstone, Director, 2012-04-03
E Raul Kohan, Exe Vice President, 2012-01-04
E Thomas Shenk, Director, 2011-05-31
R Harry Jacobson, Director, 2011-05-31
Mervyn Turner, Chief Strategy Officer, 2011-03-01
T Richard Clark, Chairman, 2011-03-01
F Stanley Barshay, Exvp&presconshlthcare, 2010-03-05
Md O Samuel Thier, Director, 2009-11-05
R Eugene Mcgrath, Director, 2009-11-04
J Thomas Colligan, Director, 2009-11-04
F Arthur Weinbach, Director, 2009-11-04
L Jack Stahl, Director, 2009-11-04
L Brent Saunders, Officer, 2009-11-04
C Kathryn Turner, Director, 2009-11-04
Jr J Thomas Sabatino, Officer, 2009-11-04
Fw Robert Oordt Van, Director, 2009-11-04
Smith Carrie Cox, Officer, 2009-11-04
H Steven Koehler, Officer, 2009-11-04
P Thomas Koestler, Officer, 2009-11-04
Fred Hassan, Officer, Director, 2009-11-04
J Robert Bertolini, Officer, 2009-11-04
Ron C Cheeley, Officer, 2009-11-04
Jr E Carl Mundy, Director, 2009-06-02

Show All Insiders (80)

Hedge Fund Holdings

Filing Period:

Last updated on September 15, 2021, 2:42 pm based on SEC 13F filings Last update: September 15, 2021, 2:42 pm

No.	Hedge Fund	Shares	Value (x$1000)	Activity	% Port
1.	Kahn Brothers Irving Kahn	716,329	$55,708,931	+2%	7.97%
2.	Fisher Asset Management Ken Fisher	10,316,812	$802,339	+5%	0.5%
3.	Berkshire Hathaway Warren Buffett	9,157,192	$712,155	-49%	0.24%
4.	Two Sigma Advisors John Overdeck And David Siegel	5,479,299	$426,125	+51%	1.12%
5.	Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell	5,394,474	$419,528	-17%	0.51%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Frazier	$31.77	12,236	Officer, Director	192,520	2011-08-15	Filing
Frazier	$31.78	19,764	Officer, Director	180,284	2011-08-15	Filing
Kellogg	$31.80	200	Officer	53,999	2011-08-12	Filing
Kellogg	$31.77	1,635	Officer	53,799	2011-08-12	Filing
Kellogg	$31.80	4,000	Officer	52,164	2011-08-12	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Clyburn	$78.32	19,324	Officer	94,348	2021-05-10	Filing
Frazier	$81.74	144,866	Officer, Director	411,546	2020-11-09	Filing
Frazier	$81.08	135,134	Officer, Director	556,412	2020-11-09	Filing
Davis	$81.03	251,273	Officer	171,056	2020-10-05	Filing
Chattopadhyay	$83.01	10,380	Officer	67,373	2020-08-13	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value (x$1000)	% Port
1.	Ubs Asset Management Americas Inc	11,628,859	$904,376,364	0.38%
2.	Bnp Paribas Arbitrage, Sa	1,723,780	$134,058,371	0.19%
3.	Dnb Asset Management As	626,073	$48,689,697	0.32%
4.	Westpac Banking Corp	388,379	$30,204,235	0.3%
5.	Heritage Wealth Advisors	258,543	$20,106,856	1.23%

News See All

Click here to See All News